Marc Young
Albert Einstein Allee 11
Ulm, BW, Germany
Ulm, BW, Germany
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
IGLV3-21R110 and ibrutinib treatment: Results from the double-blind, randomized, placebo-controlled GCLLSG CLL12 trial in early-stage CLL.
Journal: HemaSphere
Published: December 05, 2025
IgD-Expressing Mature B Cells Exhibit Enhanced Sensitivity to Glucocorticoid-Induced Cell Death.
Journal: European journal of immunology
Published: June 05, 2025
Rheumatoid factor IgM autoantibodies control IgG homeostasis.
Journal: Frontiers in immunology
Published: August 10, 2022
Autoreactive antibodies control blood glucose by regulating insulin homeostasis.
Journal: Proceedings of the National Academy of Sciences of the United States of America
Published: December 23, 2021
Primary Immune Responses and Affinity Maturation Are Controlled by IgD.
Journal: Frontiers in immunology
Published: May 13, 2021
IGLV3-21*01 is an inherited risk factor for CLL through the acquisition of a single-point mutation enabling autonomous BCR signaling.
Journal: Proceedings of the National Academy of Sciences of the United States of America
Published: February 13, 2020
Synergism between IL7R and CXCR4 drives BCR-ABL induced transformation in Philadelphia chromosome-positive acute lymphoblastic leukemia.
Journal: Nature communications
Published: August 08, 2019
Showing 1-9 of 9
Last Updated: 09/26/2026